Presence and severity of coronary artery disease and changes in B-type natriuretic peptide levels in patients with a normal systolic function

Translational Research

Volumn 148, Issue 4, 2006, Pages 188-195

  Kim, Bum Soo ^a   Lee, Hyun Jong ^a   Shin, Hun Sub ^a   Yoon, Jang Hyuk ^a   Lee, Hyun Young ^a   Kim, Byung Jin ^a   Sung, Ki Chul ^a   Kang, Jin Ho ^a   Lee, Man Ho ^a   Park, Jung Ro ^a  

^a School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; EXERCISE; FEMALE; HEART FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLE;

EID: 33748757889     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2006.04.004     Document Type: Article

References (32)

1. Sudoh T., Kanagawa K., Minamino N., and Matsuo H. A new natriuretic peptide in porcine brain. Nature 332 (1988) 78-81
2. Mukoyama M., Nakao K., Hosoda K., Suga S., Saito Y., Ogawa Y., et al. Brain natriuretic peptide as a novel cardiac hormone in humans. J Clin Invest 87 (1991) 1402-1412
3. Cowie M.R., and Mendez G.F. BNP and congestive heart failure. Prog Cardiovasc Dis 44 (2002) 293-321
4. Nakamura M., Endo H., Nasu M., Arakawa N., Segawa T., and Hiramori K. Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population. Heart 87 (2002) 131-135
5. Morita E., Yasue H., Yoshimura M., Ogawa H., Jougasaki M., Matsmura T., et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88 (1993) 82-91
6. Bibbins-Domingo K., Ansari M., Schiller N.B., Massie B., and Whooley M.A. B-type natriuretic peptide and ischemia in patients with stable coronary disease. Data from the heart and soul study. Circulation 108 (2003) 2987-2992
7. Marumoto K., Hamada M., and Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci (Lond) 88 (1995) 551-556
8. Tateishi J., Masutani M., Ohyanagi M., and Iwasaki T. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol 23 (2000) 776-780
9. Foote R.S., Pearlman J.D., Siegel A.H., and Yeo K.T. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Amer Coll Cardiol 44 (2004) 1980-1987
10. Win H.K., Chang S.M., Raizner M., Shah G., Al Basky F., Desai U., et al. Percent change in B-type natriuretic peptide levels during treadmill exercise as a screening test for exercise-induced myocardial ischemia. Am Heart J 150 (2005) 695-700
11. Weber M., Dill T., Arnold R., Rau M., Ekinci O., Muller K.D., et al. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J 148 (2004) 612-620
12. Sabatine M.S., Morrow D.A., de Lemos J.A., Omland T., Desai M.Y., Tanasijevic M., et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Amer Coll Cardiol 44 (2004) 1988-1995
13. Gibbons R.J., Balady G.J., Bricker J.T., Chaitman B.R., Fletcher G.F., Froelicher V.F., et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Amer Coll Cardiol 40 (2002) 1531-1540
14. Sahn D.J., DeMaria A., Kisslo J., and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
15. Talwar S., Squire I.B., Downie P.F., Mccullough A.M., Campton M.C., Davies J.E., et al. Profile of plasma N-terminal proBNP following acute myocardial infarction: correlation with left ventricular systolic dysfunction. Eur Heart J 21 (2000) 1514-1521
16. Morita E., Yasue H., Yoshimura M., Ogawa H., Jougasaki M., Matsumura T., et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88 (1993) 82-91
17. Darbar D., Davidson N.C., Gillespie N., Choy A.M., Lang C.C., Shyr Y., et al. Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction. Amer J Cardiol 78 (1996) 284-287
18. Talwar S., Squire I.B., Downie P.F., Davies J.E., and Ng L.L. Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart 84 (2000) 421-424
19. Struthers A.D., and Davies J. B-type natriuretic peptide: a simple new test to identify coronary artery disease. QJM 98 (2005) 765-769
20. D'Souza S.P., Yellon D.M., Martin C., Schulz R., Heusch G., Onody A., et al. B-Type natriuretic peptide (BNP) limits infarct size in rat isolated heart via KATP channel opening. Amer J Physiol Heart Circ Physiol 284 (2003) H1592-H1600
21. Baxter G.F., and Ebrahim Z. Role of bradykinin in preconditioning and protection of the ischaemic myocardium. Br J Pharmacol 135 (2002) 843-854
22. D'Souza S.P., Yellon D.M., and Baxter G.F. Cardioprotective action of B-type natriuretic peptide is NO-dependent. [abstract]. Br J Pharmacol 138 (2003) 21
23. D'Souza S.P., and Baxter G.F. B-type natriuretic peptide: a good omen in myocardial ischaemia. Heart 89 (2003) 707-709
24. Tanaka M., Ishizaka Y., Ishiyama Y., Kato J., Kida O., Kitamura K., et al. Exercise-induced secretion of brain natriuretic peptide in essential hypertension and normal subjects. Hypertens Res 18 (1995) 159-166
25. Nishikimi T., Morimoto A., Ishikawa K., Saito Y., Kangawa K., Matsuo H., et al. Different secretion patterns of adrenomodullin, brain natriuretic peptide and atrial natriuretic peptide during exercise in hypertensive and normotensive subjects. Clin Exp Hypertens 19 (1997) 503-518
26. Steele I.C., McDowell G., Moore A., Campbell N.P., Shaw C., Buchanan K.D., et al. Responses of atrial natriuretic peptide and brain natriuretic peptide to exercise in patients with chronic heart failure and normal control subjects. Eur J Clin Invest 27 (1997) 270-276
27. Nicholson S., Richards M., Espiner E., Nicholls G., and Yandle T. Atrial and brain natriuretic peptide response to exercise in patients with ischemic heart disease. Clin Exp Pharmacol Physiol 20 (1993) 535-540
28. Marie P.Y., Mertes P.M., Hassan-Sebbag N., de Talence N., Djaballah K., Djaballah W., et al. Exercise release of cardiac natriuretic peptides is markedly enhanced when patients with coronary artery disease are treated medically by beta-blockers. J Amer Coll Cardiol 43 (2004) 353-359
29. Ueda R., Yokouchi M., Suzuki T., Otomo E., and Katagiri T. Prognostic value of high plasma brain natriuretic peptide concentrations in very elderly persons. Amer J Med 114 (2003) 266-270
30. Sayama H., Nakamura Y., Saito N., and Kinoshita M. Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal?. Coron Artery Dis 10 (1999) 537-540
31. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., Mahoney D.W., Bailey K.R., and Burnett Jr. J.C. Plasma brain natriuretic peptide concentration: impact of age and gender. J Amer Coll Cardiol 40 (2002) 976-982
32. Yamaguchi H., Yoshida J., Yamamoto K., Sakata Y., Mano T., Akehi N., et al. Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy. J Amer Coll Cardiol 43 (2004) 55-60